نتایج جستجو برای: tp53 protein

تعداد نتایج: 1240012  

Journal: :iranian journal of public health 0
farhad babaei 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. seyed ali ahmadi 2. school of medicine, tehran university of medical sciences , tehran, iran. ramin abiri 3. dept. of microbiology, school of medicine, kermanshah university of medical sciences , kermanshah, iran. farhad rezaei 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. maryam naseri 1. dept. of virology, school of public health, tehran university of medical sciences , tehran, iran. mahmoud mahmoudi 4. dept. of epidemiology and biostatistics, school of public health, tehran university of medical sciences , tehran, iran.

the tp53 gene is one of the most frequently mutated genes amongst human malignancies, particularly tp53 codon 72 polymorphism. furthermore, an association between the tp53 codon 72 variants and prostate cancer has been reported in several studies. although some studies have indicated an association between the tp53 arg/arg variant and an increased risk for prostate cancer, other studies have sh...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Stephanie Geisler Anne-Lise Børresen-Dale Hilde Johnsen Turid Aas Jürgen Geisler Lars Andreas Akslen Gun Anker Per Eystein Lønning

PURPOSE Recent studies have found an association between certain TP53 mutations and resistance to anthracycline-based primary medical therapy in breast cancer. The purpose of this study was to investigate whether TP53 mutational status also might influence the response to a non-anthracycline-containing regimen in primary breast cancer. EXPERIMENTAL DESIGN Thirty-five patients with locally adv...

2013
Angeles Alvarez Secord Marcus Q. Bernardini Gloria Broadwater Lisa A. Grace Zhiqing Huang Tsukasa Baba Eiji Kondoh Gregory Sfakianos Laura J. Havrilesky Susan K. Murphy

OBJECTIVES To elucidate the association between thrombospondin1 (THBS1) expression and TP53 status and THBS1 promoter methylation in epithelial ovarian cancer (EOC). METHODS Epithelial ovarian cancer cell lines with known TP53 status were analyzed for THBS1 gene expression using Affymetrix U133 microarrays and promoter methylation by pyrosequencing. THBS1 mRNA expression was obtained pre- and...

Journal: :Cancer research 2003
Magali Olivier David E Goldgar Nayanta Sodha Hiroko Ohgaki Paul Kleihues Pierre Hainaut Rosalind A Eeles

A database has been created to collect information on families carrying a germ-line mutation in the TP53 gene and on families affected with Li-Fraumeni syndromes [Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like syndrome (LFL)]. Data from the published literature have been included. The database is available online at http://www.iarc.fr/p53, as part of the IARC TP53 Database. The analysis of the...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2015
Sarah Croessmann Hong Yuen Wong Daniel J Zabransky David Chu Janet Mendonca Anup Sharma Morassa Mohseni D Marc Rosen Robert B Scharpf Justin Cidado Rory L Cochran Heather A Parsons W Brian Dalton Bracha Erlanger Berry Button Karen Cravero Kelly Kyker-Snowman Julia A Beaver Sushant Kachhap Paula J Hurley Josh Lauring Ben Ho Park

The tumor protein 53 (TP53) tumor suppressor gene is the most frequently somatically altered gene in human cancers. Here we show expression of N-Myc down-regulated gene 1 (NDRG1) is induced by p53 during physiologic low proliferative states, and mediates centrosome homeostasis, thus maintaining genome stability. When placed in physiologic low-proliferating conditions, human TP53 null cells fail...

2011
Anna Felisiak-Golabek Alina Rembiszewska Iwona K Rzepecka Lukasz Szafron Radoslaw Madry Magdalena Murawska Tomasz Napiorkowski Piotr Sobiczewski Beata Osuch Jolanta Kupryjanczyk

BACKGROUND Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53 status. METHODS Survivin and TP53 expression was evaluated immunohistochemically in 435 archiva...

2016
Xiaomei Lv Zhenhong Cai Su Li

In the present study, we analyzed the proliferation and apoptosis of trophoblasts and human decidual cells in patients with recurrent spontaneous abortion and the related cellular pathway mechanism. Thirty-four patients with recurrent abortion and 30 healthy pregnant women undergoing planned artificial abortion were selected. The trophoblast and decidual cells were collected by negative pressur...

Journal: :Blood 2016
Marwan Kwok Nicholas Davies Angelo Agathanggelou Edward Smith Ceri Oldreive Eva Petermann Grant Stewart Jeff Brown Alan Lau Guy Pratt Helen Parry Malcolm Taylor Paul Moss Peter Hillmen Tatjana Stankovic

TP53 and ataxia telangiectasia mutated (ATM) defects are associated with genomic instability, clonal evolution, and chemoresistance in chronic lymphocytic leukemia (CLL). Currently, therapies capable of providing durable remissions in relapsed/refractory TP53- or ATM-defective CLL are lacking. Ataxia telangiectasia and Rad3-related (ATR) mediates response to replication stress, the absence of w...

Journal: :Atlas of Genetics and Cytogenetics in Oncology and Haematology 2018

2012
Marilanda Ferreira Bellini Aline Cristina Targa Cadamuro Maysa Succi Marcela Alcântara Proença Ana Elizabete Silva

TP53 genes is one of more important tumor suppressor gene, which acts as a potent transcription factor with fundamental role in the maintenance of genetic stability. The development of esophageal and gastric cancers is a multistep process resulting in successive accumulation of genetic alterations that culminates in the malignant transformation. Thus, this study highlights the participation of ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید